TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
The Republican-controlled Committee on Oversight and Government Reform approved a bill earlier today to allow for a congressional audit of the Federal Reserve’s monetary policy, a proposal Fed policymakers have opposed and likely faces a difficult path to final approval in the Senate. Under the bill, the Fed’s monetary policy deliberations could be subject to Read More…
Riddle me this: As we all know by now, China is bleeding capital, with a record $725 billion in outflows last year alone. Accordingly, the ChiComs have been flipping their lid, imposing new capital controls left and right to try and stop the bleeding. One of the most straightforward of these capital controls limits each Read More…
As Attorney General Jeff Sessions continues to lament what he views as a blight on society, a new study is showing that states with medical marijuana programs are seeing drastic reductions in opioid-related hospitalizations and overdoses. From a Reuters article published Tuesday: “In states that legalized medical marijuana, U.S. hospitals failed to see a predicted influx Read More…
Today, the West Virginia House unanimously passed a bill that would significantly expand the state’s hemp licensing program, opening the door for anybody in the state to produce or process industrial hemp for commercial purposes. Final approval would set the foundation to end federal prohibition in practice. Del. Jeff Eldridge (D-Alum Creek) and Del. Jim Butler (R-Henderson) Read More…
German researchers have discovered endocrine disrupting chemicals (EDCs), which could adversely affect development and reproduction, to be contained in 18 different bottled water products. Of the 24,520 suspect chemicals found to be present in bottled water, the one that showed consistent results and illustrated anti-androgenic and anti-estrogenic activity is di(2-ethylhexyl) fumarate (DEHF). Endocrine disruptors are chemicals Read More…
After it waged a veritable war against cannabis legalization in Arizona, coughing up half a million dollars for the campaign, Insys Therapeutics recently announced the ultimate victory has finally come to fruition: the DEA approved one of the company’s groundbreaking pharmaceuticals — synthetic marijuana — to be listed as a Schedule II substance. “Insys gave $500,000 last Read More…